NRx Pharmaceuticals Inc.
NRXP | NASDAQ
$3.27
-$0.02 (-0.61%)
Sep 22, 2026, 11:01 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.1M | 1.07M | 983K | 242K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 843K | 796K | 508K | 138K | n/a | n/a | 1K | 2K | 1K | 1K | 1K | 2K | 1K | 1K | 1K | 1K | 1K | 1K | 395 | 638 | 967 | n/a |
Gross Profit | 258K | 272K | 475K | 104K | n/a | n/a | -1K | -2K | -1K | -1K | -1K | -2K | -1K | -1K | -1K | -1K | -1K | -1K | -395 | -638 | -967 | n/a |
Operating Income | -6.51M | -4.75M | -4.59M | -4.12M | -3.73M | -3.85M | -3.63M | -3.02M | -7.05M | -6M | -4.41M | -5.81M | -7.94M | -9.44M | -9.89M | -9.14M | -9.6M | -15.71M | -52.97M | -20.1M | -17.12M | -5.01M |
Interest Income | 6K | 5K | 4K | 2K | 2K | 4K | 4K | 6K | 7K | 27K | 74K | 119K | 145K | 156K | 130K | 95K | 23K | n/a | n/a | 368 | n/a | n/a |
Pretax Income | -16.52M | -1.43M | 360K | -5.89M | -17.58M | -5.51M | -9.08M | -1.62M | -7.9M | -6.53M | -4.33M | -6.06M | -8.72M | -11.04M | -10.24M | -9.08M | -6.98M | -13.45M | -30.79M | -37.05M | -117.61K | -25.49M |
Net Income | -16.52M | -1.43M | 360K | -5.89M | -17.58M | -5.51M | -9.08M | -1.62M | -7.9M | -6.53M | -4.33M | -6.06M | -8.72M | -11.04M | -10.24M | -9.08M | -6.98M | -13.45M | -30.79M | -37.05M | -117.61K | -25.49M |
Selling & General & Admin | 4.75M | 3.71M | 4.51M | 2.79M | 2.74M | 2.94M | 2.6M | 2.41M | 4.25M | 4.25M | 1.87M | 2.49M | 4.06M | 5.78M | 5.43M | 5.01M | 6.64M | 10.22M | 46.56M | 13.82M | 12.46M | 2.1M |
Research & Development | 2.12M | 1.31M | 558K | 1.43M | 987K | 804K | 1.04M | 611K | 2.8M | 1.75M | 2.53M | 3.31M | 3.87M | 3.65M | 4.46M | 4.13M | 2.96M | 5.48M | 6.41M | 6.28M | 4.66M | 2.91M |
Other Expenses | -102K | n/a | n/a | n/a | n/a | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 6.76M | 5.02M | 5.07M | 4.22M | 3.73M | 3.85M | 3.63M | 3.02M | 7.05M | 6M | 4.41M | 5.81M | 7.94M | 9.43M | 9.89M | 9.14M | 9.6M | 15.7M | 52.97M | 20.1M | 17.12M | 5.01M |
Interest Expense | 240K | 233K | 671K | n/a | n/a | n/a | n/a | n/a | 849K | 230K | 80K | 40K | n/a | n/a | n/a | n/a | n/a | 3K | 2.34K | 5.37K | 5.11K | 5K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 7.6M | 5.82M | 5.58M | 4.36M | 3.73M | 3.85M | 3.63M | 3.02M | 7.05M | 6M | 4.41M | 5.81M | 7.94M | 9.44M | 9.89M | 9.14M | 9.6M | 15.71M | 52.97M | 20.1M | 17.12M | 5.01M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 37.65M | 32.33M | 31.73M | 22.23M | 17.93M | 16.41M | 10.52M | 10.97M | 10.52M | 8.85M | 83.92M | 8.2M | 73.22M | 67.45M | 66.45M | 64.88M | 65.73M | 63.67M | 51.74M | 54.81M | 41.73M | 3.57M |
Shares Outstanding (Diluted) | 37.65M | 32.33M | 31.73M | 22.23M | 17.93M | 16.41M | 10.52M | 10.97M | 10.52M | 8.85M | 83.92M | 8.2M | 73.22M | 67.45M | 66.45M | 66.45M | 65.73M | 63.67M | 51.74M | 54.81M | 42.49M | 35.66M |
EPS (Basic) | -0.44 | -0.04 | 0.01 | -0.27 | -0.98 | -0.34 | -0.86 | -0.15 | -0.75 | -0.74 | -0.05 | -0.74 | -0.12 | -0.19 | -0.09 | -0.14 | -0.07 | -0.18 | -0.60 | -0.38 | -61.30 | -0.71 |
EPS (Diluted) | -0.44 | -0.04 | 0.01 | -0.27 | -0.98 | -0.34 | -0.86 | -0.15 | -0.75 | -0.74 | -0.05 | -0.74 | -0.12 | -0.19 | -0.09 | -0.14 | -0.07 | -2.10 | -0.60 | -0.38 | -64.30 | -7.10 |
EBITDA | -6.33M | -1.03M | 1.13M | -5.85M | -17.58M | -5.51M | -9.08M | -1.62M | -7.05M | -6.3M | -4.25M | -6.02M | -8.72M | -11.04M | -10.24M | -9.08M | -6.98M | -13.44M | -30.79M | -37.04M | -111.54K | -25.48M |
EBIT | -6.5M | -1.2M | 1.03M | -5.89M | -17.58M | -5.51M | -9.08M | -1.62M | -7.05M | -6.3M | -4.25M | -6.02M | -8.72M | -11.04M | -10.24M | -9.08M | -6.98M | -13.45M | -30.79M | -37.04M | -112.51K | -25.48M |
Depreciation & Amortization | 168K | 165K | 100K | 41K | n/a | 1K | 1K | 2K | 1K | 1K | 1K | 2K | 1K | 1K | 1K | 1K | 1K | 1K | 395 | 638 | 967 | n/a |
Add to Watchlist
Select watchlists to add or remove NRXP